Identification and antifungal susceptibility testing of two strains of Candida in 95 french hospitals;Identification et sensibilité aux antifongiques de deux souches de Candida dans 95 hôpitaux français

Journal de Mycologie Medicale

Volumn 15, Issue 3, 2005, Pages 117-126

  Eloy, O ^a   Blanc, V ^b   Mallie M ^c   Decousser, J W ^a   Pina, P ^a   Allouch, P Y ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b Centre Hospitalier d'Antibes   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Antifungal susceptibility testing; Candida; Identification; MIC

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS IDENTIFICATION; HOSPITAL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; YEAST;

CANDIDA; CANDIDA PARAPSILOSIS; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 28844509182     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2005.06.001     Document Type: Article

References (26)

1. M. Arendrup, B. Lundgren, I.M. Jensen, B.S. Hansen, and N. Frimodt-Moller Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates J. Antimicrob. Chemother. 47 2001 521 526
2. A. Birinci, L. Akkurt, C. Acuner, M. Unlu, and B. Durupinar Rapid identification of the Candida species from direct blood cultures by CHROMagar Candida J. Int. Med. Res. 32 2004 484 487
3. L. Buchaille, A.M. Freydiere, R. Guinet, and Y. Gille Evaluation of six commercial systems for identification of medically important yeasts Eur. J. Clin. Microbiol. Infect. Dis. 17 1998 479 488
4. K.G. Davey, A.D. Holmes, E.M. Johnson, A. Szekely, and D.W. Warnock Comparative evaluation of Fungitest and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans J. Clin. Microbiol. 36 1998 926 930
5. O. Eloy, V. Joly, J.C. Ghnassia, C. Carbon, and P. Yeni Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests Presse Med. 21 1992 937 942
6. A. Freydiere, and F. Odds Commercial kits for yeast identification: concerns for standardisation Eur. J. Clin. Microbiol. Infect. Dis. 20 2001 366 367
7. S. Gundes, S. Gulenc, and R. Bingol Comparative performance of Fungichrom I, Candifast and API 20C Aux systems in the identification of clinically significant yeasts J. Med. Microbiol. 50 2001 1105 1110
8. R.A. Hajjeh, A.N. Sofair, L.H. Harrison, G.M. Lyon, B.A. Arthington-Skaggs, and S.A. Mirza Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program J. Clin. Microbiol. 42 2004 1519 1527
9. G. Hall, and B. Sharon Parshall Use of the concentration gradient diffusion assay (Etest) for susceptibility testing of anaerobes, Fungi, and Mycobacterium spp Clin. Microbiol. Newsl. 24 2002 105 111
10. V. Letscher-Bru, M.H. Meyer, A.C. Galoisy, J. Waller, and E. Candolfi Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species J. Clin. Microbiol. 40 2002 1508 1510
11. V. Letscher-Bru, J. Waller, and E. Candolfi Comparaison des techniques ATB Fungus 2 et Etest pour la d́termination de la CMI de l'amphot́ricine B, du Fluconazole et de l'itraconazole J. Mycol. Med. 14 2004 164 165
12. M.J. Matar, L. Ostrosky-Zeichner, V.L. Paetznick, J.R. Rodriguez, E. Chen, and J.H. Rex Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole Antimicrob. Agents Chemother. 47 2003 1647 1651
13. G. Morace, G. Amato, F. Bistoni, G. Fadda, P. Marone, and M.T. Montagna Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species J. Clin. Microbiol. 40 2002 2953 2958
14. National committee for clinical laboratory standards Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd edn ed 2002 PA Waynes
15. P.G. Pappas, J.H. Rex, J.D. Sobel, S.G. Filler, W.E. Dismukes, and T.J. Walsh Guidelines for treatment of candidiasis Clin. Infect. Dis. 38 2004 161 189
16. M.A. Pfaller, S.A. Messer, A. Karlsson, and A. Bolmstrom Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media J. Clin. Microbiol. 36 1998 2586 2589
17. G. Quindos, R. Salesa, A.J. Carrillo-Munoz, V. Lipperheide, L. Jaudenes, and R. San Millan Multicenter evaluation of ATB fungus: a standardized micromethod for yeast susceptibility testing Chemotherapy 40 1994 245 251
18. SFAR, SPLIF and SRLF. 2004. (130504).
19. D. Swinne, C. Raes-Wuytack, K. Van Looveren, and P. Desmet Comparative evaluation of Fungitest-, Neo-Sensitabs and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans Mycoses 42 1999 231 237
20. A.M. Tortorano, J. Peman, H. Bernhardt, L. Klingspor, C.C. Kibbler, and O. Faure Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study Eur. J. Clin. Microbiol. Infect. Dis. 23 2004 317 322
21. J. van Eldere, L. Joosten, V. Verhaeghe, and I. Surmont Fluconazole and amphotericin B antifungal susceptibility testing by National committee for clinical laboratory standards broth macrodilution method compared with E-test and semiautomated broth microdilution test J. Clin. Microbiol. 34 1996 842 847
22. P. Verweij, I. Breuker, A. Rijs, and J. Meis Comparative study of seven commercial yeast identification systems J. Clin. Pathol. 52 1999 271 273
23. B. Willinger, P. Apfalter, A.M. Hirschl, A. Makristathis, M. Rotter, and M. Seibold Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest Diagn. Microbiol. Infect. Dis. 38 2000 11 15
24. B. Willinger, E. Engelmann, H. Hofmann, S. Metzger, P. Apfalter, and A.M. Hirschl Multicenter comparison of Fungitest for susceptibility testing of Candida species Diagn. Microbiol. Infect. Dis. 44 2002 253 257
25. B. Willinger, C. Hillowoth, B. Selitsch, and M. Manafi Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida J. Clin. Microbiol. 39 2001 3793 3795
26. H. Yera, D. Poulain, A. Lefebvre, D. Camus, and B. Sendid Polymicrobial candidaemia revealed by peripheral blood smear and chromogenic medium J. Clin. Pathol. 57 2004 196 198